1. Home
  2. CRMT vs MRKR Comparison

CRMT vs MRKR Comparison

Compare CRMT & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$3.31

Market Cap

19.7M

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.61

Market Cap

22.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRMT
MRKR
Founded
1981
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
22.5M
IPO Year
2026
2010

Fundamental Metrics

Financial Performance
Metric
CRMT
MRKR
Price
$3.31
$1.61
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$29.50
$10.00
AVG Volume (30 Days)
2.7M
64.6K
Earning Date
06-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
147.36
33.61
EPS
N/A
N/A
Revenue
$1,390,932,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.92
$936.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$0.81
52 Week High
$60.67
$4.07

Technical Indicators

Market Signals
Indicator
CRMT
MRKR
Relative Strength Index (RSI) 38.01 66.31
Support Level $1.38 $1.35
Resistance Level $4.24 $1.69
Average True Range (ATR) 0.57 0.08
MACD 0.35 0.03
Stochastic Oscillator 55.24 78.51

Price Performance

Historical Comparison
CRMT
MRKR

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Share on Social Networks: